Establishment of risk-reducing salpingo-oohorectomy for hereditary breast and ovarian syndrome

Not Applicable

Recruiting

• Conditions: ovarian cancer tubal cancer

• Registration Number: JPRN-UMIN000024515
• Lead Sponsor: Fujita Health University, Gynecology and Obstetrics

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-11-01
• Last Update Posted: 17 October 2023
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 5

Inclusion Criteria

Not provided

Exclusion Criteria

Female with mental disabilities and who has difficulty to make a determination of therapy. Female has active invasive cancer (except for basal cell carcinoma and squamous cell carcinoma and carcinoma in situ). Female during pregnancy and lactation. Femele with following diseases (thrombotic and hemorrhagic disease, uncontrollable hypertension, unstable renal failure, unstable hepatic failure, unhealed wound, unhealed ulcer, and unhealed fracture). Female who a doctor consider inappropriate

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
prognosis(OS, acquiring and recurrence of BRCA related cancer

Secondary Outcome Measures

Name	Time	Method
menopausal problem occult cancer QOL of women after RRSO(EORTC QLQ-OV28)